Whitehawk Therapeutics (WHWK) Change in Acquisitions & Divestments (2022 - 2026)

Whitehawk Therapeutics (WHWK) has 5 years of Change in Acquisitions & Divestments data on file, last reported at $38.6 million in Q1 2026.

• Change in Acquisitions & Divestments for Q1 2026 came in at $38.6 million, up 162.82% year-over-year; the trailing twelve-month figure through Mar 2026 was $83.8 million (up 41.76% YoY), and the FY2025 annual result was $59.8 million, down 5.51% from the prior year.
• Change in Acquisitions & Divestments fell to $38.6 million in Q1 2026 per WHWK's latest filing, from $39.8 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $51.2 million in Q2 2023 and troughed at $2.0 million in Q3 2025.
• A 5-year average of $23.3 million and a median of $17.1 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
• On a YoY basis, Change in Acquisitions & Divestments climbed as much as 198.57% in 2025 and fell as far as 86.86% in 2025.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $12.8 million in 2022, then jumped by 44.02% to $18.4 million in 2023, then retreated by 27.47% to $13.3 million in 2024, then surged by 198.57% to $39.8 million in 2025, then slipped by 2.89% to $38.6 million in 2026.
• Business Quant data shows WHWK's Change in Acquisitions & Divestments at $38.6 million in Q1 2026, $39.8 million in Q4 2025, and $2.0 million in Q3 2025.